Published on 16/11/2025

EDC Build Fundamentals: From Requirements Gathering to Go-Live

In the evolving landscape of clinical trials, electronic data capture (EDC) has emerged as a vital tool for ensuring data integrity, enhancing efficiency, and facilitating regulatory compliance. As professionals involved in clinical operations, regulatory affairs, and medical affairs, understanding the fundamentals of EDC build is essential to navigate the complexities of clinical trial management effectively.

Step 1: Understanding the Clinical Trial Landscape

Before embarking on an EDC build, it’s crucial to have a thorough grasp of the clinical trial environment, particularly in the context of msa clinical trials. This understanding not only encompasses regulatory requirements but also the specific needs of the study at hand.

Clinical trials are subject to strict guidelines set forth by regulatory agencies such as the FDA in the U.S., the EMA in the EU, and the MHRA in the UK. Familiarity with these regulations is paramount in ensuring compliance throughout the EDC build process.

The clinical trial landscape has seen significant advancements, particularly in technologies that streamline data collection and management. EDC systems are particularly advantageous in trials involving complex data requirements, such as those seen in non small cell lung cancer clinical trials. These trials often demand real-time data entry and reporting capabilities to monitor safety and efficacy effectively.

In addition, understanding related studies, such as the aegean clinical trial and mariposa clinical trial, provides insights into the specific data capturing needs and regulatory considerations for particular therapeutic areas.

• Review pertinent regulations from the FDA, EMA, and MHRA.
• Study similarities and differences in procedures across trials.
• Document the specific requirements based on therapeutic areas.

Step 2: Requirements Gathering

The next step in the EDC build process is requirements gathering. This stage is critical for defining the parameters within which the EDC system will operate. It involves engaging with stakeholders, including clinical trial professionals, data managers, regulatory teams, and IT specialists, to collect their requirements.

Begin by conducting workshops and interviews to capture the functional requirements. Consider the following aspects:

• Data Collection Needs: Determine what data will be collected and how it will be structured. For example, will the study involve the collection of lab results, patient-reported outcomes, or both?
• User Roles and Permissions: Define who will have access to the system and what level of data they can modify or view.
• Reporting Requirements: Craft a clear vision for the reports that will be generated, including real-time dashboards and standard reports for regulatory submissions.

It is beneficial to leverage standardized data collection formats, such as CDISC standards, to ensure consistency and facilitate regulatory compliance. One effective approach is to create a traceability matrix that links each requirement back to the original study protocol.

Step 3: Designing the EDC System

The design process transforms requirements into a structured EDC system. This includes deciding on the software platform and how data will be organized. Whether developing a custom solution or using an off-the-shelf product, the design should allow for flexibility and scalability.

Key components to consider during the design phase include:

• Data Structure: Establish logical forms and data entry fields based on the requirements. Ensure that fields are designed to minimize entry errors and enhance user experience.
• Workflow: Map out the data flow within the system. Consider how data will move from entry to monitoring and analysis.
• Integration: Plan for the integration of the EDC system with other clinical trial management systems (CTMS), laboratory information systems, and safety reporting tools, ensuring seamless data transfers.

The design process should align with the regulatory expectations outlined in documents such as the ICH E6 guidelines for Good Clinical Practice, which emphasize the need to adhere to quality principles throughout the clinical trial lifecycle.

Step 4: Development and Configuration

Once the design phase is finalized, the focus shifts to the development and configuration of the EDC system. Strong project management techniques should be employed to ensure that the development adheres to the timelines and budget constraints.

During this phase, the following activities must be undertaken:

• System Build: Develop the EDC tool as per the specifications established during the design phase. Regular communication with developers is necessary to address any challenges promptly.
• Validation: Conduct a thorough validation process, including unit testing, system testing, and user acceptance testing (UAT). This ensures that the system performs as intended and meets all regulatory requirements.
• Documentation: Maintain detailed records of the build process, methodologies employed, and any deviations from the original plan. This documentation is essential for regulatory submissions and audits.

Step 5: User Acceptance Testing (UAT)

User Acceptance Testing (UAT) serves as a critical checkpoint to ensure the EDC system is functioning correctly and meets the predefined requirements before going live. UAT is conducted by the end-users who will interact with the EDC system during the clinical trial.

When planning for UAT, consider the following:

• Define Test Scenarios: Create realistic scenarios that the users are likely to encounter in their daily operations.
• Evaluate User Feedback: Gather feedback from users during testing sessions to identify any usability issues or functional gaps that need addressing.
• Iterative Testing: Adopt an iterative approach, allowing users to retest after modifications are made to resolve issues raised during UAT.

Documenting the testing outcomes is crucial for regulatory compliance and for future audits, ensuring that the system has been validated and is fit for purpose.

Step 6: Training and Go-Live Preparation

Preparation for the go-live phase involves extensive training for all users of the EDC system. A well-structured training program not only includes system navigation but also emphasizes data integrity and compliance with regulatory standards.

Key aspects of training include:

• User Manuals: Provide user manuals that are clear and concise, detailing all functionalities of the EDC system.
• Training Sessions: Conduct hands-on training sessions to familiarize users with the system. This can include webinars, in-person training, and workshops.
• Support Mechanisms: Establish a helpdesk or support mechanism that users can access while they familiarize themselves with the new system.

As you approach the go-live phase, ensure all stakeholders are aware of their responsibilities and timelines. Prepare for a soft launch or pilot phase where the system is tested in a live environment for a limited number of trials before a full-scale rollout.

Step 7: Monitoring and Post-Go-Live Support

After the EDC system is launched, ongoing monitoring and support are vital for sustaining data integrity and operational efficiency. Post-launch activities should include the following:

• Real-Time Monitoring: Continuously monitor the system for any issues in data collection or user experience. Collect feedback to identify areas for improvement.
• Maintenance Schedule: Plan for regular updates and maintenance to ensure the EDC system remains compliant with evolving regulatory requirements and technological advancements.
• Audit and Compliance Checks: Conduct periodic audits to ensure continued adherence to GCP guidelines and other relevant regulations.

This ongoing support and maintenance phase establishes a feedback loop for continual improvement, ensuring that the EDC system adapts to meet the changing needs of upcoming clinical trials and regulatory landscapes.

Conclusion

The journey from requirements gathering to go-live for an EDC system is complex but essential for the success of clinical trials. By adhering to a systematic approach and focusing on regulatory compliance, clinical operations, regulatory affairs, and medical affairs professionals can effectively manage the EDC build process. Integrating user feedback and maintaining open lines of communication between all stakeholders ensures the system’s efficacy in capturing data, thus improving the overall quality and success of clinical trials.

By applying these fundamental principles, professionals will be well-equipped to navigate the requirements of various clinical trials, including specialties such as smo in clinical research, while maintaining the highest standards of data integrity and compliance.